VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,056,000 | -23.2% | 417,100 | +29.9% | 0.21% | +28.2% |
| Q3 2016 | $7,885,000 | +92.1% | 321,200 | +57.6% | 0.16% | +18.1% |
| Q2 2016 | $4,104,000 | +54.8% | 203,752 | +102.0% | 0.14% | +76.9% |
| Q1 2016 | $2,652,000 | +53.5% | 100,852 | +1059.2% | 0.08% | +62.5% |
| Q1 2015 | $1,728,000 | -87.8% | 8,700 | -92.8% | 0.05% | -95.0% |
| Q4 2013 | $14,111,000 | -18.1% | 120,200 | -27.2% | 0.96% | -38.1% |
| Q3 2013 | $17,235,000 | -48.0% | 165,200 | -57.1% | 1.56% | -54.2% |
| Q2 2013 | $33,141,000 | – | 385,000 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |